| Literature DB >> 10319874 |
S Engelender1, Z Kaminsky, X Guo, A H Sharp, R K Amaravi, J J Kleiderlein, R L Margolis, J C Troncoso, A A Lanahan, P F Worley, V L Dawson, T M Dawson, C A Ross.
Abstract
Parkinson disease (PD) is a neurodegenerative disease characterized by tremor, bradykinesia, rigidity and postural instability. Post-mortem examination shows loss of neurons and Lewy bodies, which are cytoplasmic eosinophilic inclusions, in the substantia nigra and other brain regions. A few families have PD caused by mutations (A53T or A30P) in the gene SNCA (encoding alpha-synuclein). Alpha-synuclein is present in Lewy bodies of patients with sporadic PD, suggesting that alpha-synuclein may be involved in the pathogenesis of PD. It is unknown how alpha-synuclein contributes to the cellular and biochemical mechanisms of PD, and its normal functions and biochemical properties are poorly understood. To determine the protein-interaction partners of alpha-synuclein, we performed a yeast two-hybrid screen. We identified a novel interacting protein, which we term synphilin-1 (encoded by the gene SNCAIP). We found that alpha-synuclein interacts in vivo with synphilin-1 in neurons. Co-transfection of both proteins (but not control proteins) in HEK 293 cells yields cytoplasmic eosinophilic inclusions.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10319874 DOI: 10.1038/8820
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330